Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04134000
Title Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE) (BladderGATE)
Acronym BladderGATE
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fundacion Oncosur
Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.